Your browser doesn't support javascript.
loading
Amalgamation of in-silico, in-vitro and in-vivo approach to establish glabridin as a potential CYP2E1 inhibitor.
Bhatt, Shipra; Kumar, Vinay; Dogra, Ashish; Ojha, Probir Kumar; Wazir, Priya; Sangwan, Payare Lal; Singh, Gurdarshan; Nandi, Utpal.
  • Bhatt S; PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
  • Kumar V; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Dogra A; Drug Theoretics and Chemoinformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.
  • Ojha PK; PK-PD, Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India.
  • Wazir P; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Sangwan PL; Drug Theoretics and Chemoinformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.
  • Singh G; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Nandi U; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
Xenobiotica ; 51(6): 625-635, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33539218
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP2E1 / Isoflavonas Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP2E1 / Isoflavonas Idioma: En Año: 2021 Tipo del documento: Article